Delivery Order SPE2DB22D3501-SPE2DB24FWL53

Award Date 7/30/24
Potential Completion Date 8/20/24
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,115.18 firm fixed-price delivery order is for PROQUAD VIALS (4561630029) and has an ultimate completion date of August 11, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of PROQUAD VIALS. The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $3,141.08. The contract has an Ultimate Completion Date of September 24, 2024 and was awarded on September 3, 2024. This award is not associated with a set-aside program and is considered a Child contract. AmerisourceBergen,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $10,961.96, is for the delivery of PROQUAD VIALS medical supplies. The contract is a Firm Fixed Price Delivery Order with a period of performance running through March 27, 2025. The contract award was not set aside for any specific business designation. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,247.58 firm fixed-price delivery order is for the supply of PROQUAD VIALS, a medical product. The contract has a completion date of December 26, 2024 and was awarded on December 4, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,570.54 firm fixed-price delivery order is for the provision of PROQUAD VIALS, a medical product. The contract has an ultimate completion date of August 7, 2024 and was awarded on July 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,654.33 firm fixed-price delivery order is for PROQUAD VIALS, a pharmaceutical product, with a period of performance through February 13, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,687.48 Firm Fixed Price delivery order contract is for the procurement of PROQUAD VIALS, with a period of performance through March 17, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,654.33, is a delivery order for PROQUAD VIALS and has a completion date of February 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
The federal contract award summarized here is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA), a defense agency. The $1,687.48 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 4, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,374.96, is for the delivery of PROQUAD VIALS medical supplies. It is a firm fixed-price delivery order with an ultimate completion date of February 20, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWL53
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PROQUAD VIALS. The $3,203.98 Firm Fixed Price Delivery Order has an ultimate completion date of August 20, 2024. AmerisourceBergen holds a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a range of medical commodities to support military treatment programs and facilities worldwide. This specific award is not associated with a set-aside program.

Generated 10/29/24, 9:17 AM